Sign up to save your podcasts
Or
Share Human Insight Plus AI: A Winning Combination For Drug Development with Liesbeth Ceelen, CEO, and Arjan van Manen, Commercial Director of BioLizard
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Human Insight Plus AI: A Winning Combination For Drug Development with Liesbeth Ceelen, CEO, and Arjan van Manen, Commercial Director of BioLizard
This podcast is brought to you by Outcomes Rocket, your exclusive healthcare marketing agency. Learn how to accelerate your growth by going to outcomesrocket.com
The crucial combination of human expertise and AI is paramount for success in drug development.
In this episode, Liesbeth Ceelen, CEO, and Arjan van Manen, Commercial Director of BioLizard, discuss the critical role of data analytics and machine learning in the pharmaceutical industry, highlighting the increasing need for companies to become data-driven. They emphasize how a deep understanding of biology, supported by AI, can optimize target discovery and reduce clinical trial failures. BioLizard offers the expertise and a platform to support biotech and pharma companies in this new data-driven approach as the industry shifts from viewing data analysis as a cost to a necessity for better outcomes. Finally, they touch upon predictions for 2025, focusing on a more data-supported approach to drug development, tailored treatments, and a heightened focus on target mechanisms while remaining optimistic about the changing mindset of industry stakeholders.
Tune in and learn how data analytics can transform your approach to drug development!
Fast Track Your Business Growth:
Outcomes Rocket is a full service marketing agency focused on helping healthcare organizations like yours maximize your impact and accelerate growth. Learn more at outcomesrocket.com
View all episodes
By Saul Marquez
4.9
111111 ratings
This podcast is brought to you by Outcomes Rocket, your exclusive healthcare marketing agency. Learn how to accelerate your growth by going to outcomesrocket.com
The crucial combination of human expertise and AI is paramount for success in drug development.
In this episode, Liesbeth Ceelen, CEO, and Arjan van Manen, Commercial Director of BioLizard, discuss the critical role of data analytics and machine learning in the pharmaceutical industry, highlighting the increasing need for companies to become data-driven. They emphasize how a deep understanding of biology, supported by AI, can optimize target discovery and reduce clinical trial failures. BioLizard offers the expertise and a platform to support biotech and pharma companies in this new data-driven approach as the industry shifts from viewing data analysis as a cost to a necessity for better outcomes. Finally, they touch upon predictions for 2025, focusing on a more data-supported approach to drug development, tailored treatments, and a heightened focus on target mechanisms while remaining optimistic about the changing mindset of industry stakeholders.
Tune in and learn how data analytics can transform your approach to drug development!
Fast Track Your Business Growth:
Outcomes Rocket is a full service marketing agency focused on helping healthcare organizations like yours maximize your impact and accelerate growth. Learn more at outcomesrocket.com
More shows like Outcomes Rocket
View all
WSJ What’s News
4,364 Listeners
HBR IdeaCast
177 Listeners
WSJ Your Money Briefing
1,756 Listeners
The McKinsey Podcast
381 Listeners
Planet Money
30,845 Listeners
Bloomberg Intelligence
401 Listeners
Coaching for Leaders
1,462 Listeners
a16z Podcast
1,040 Listeners
Up First from NPR
56,231 Listeners
KFF Health News' 'What the Health?'
478 Listeners
The Daily Stoic
4,790 Listeners
Becker’s Healthcare Podcast
184 Listeners
Morning Brew Daily
2,969 Listeners
Think Fast Talk Smart: Communication Techniques
799 Listeners
Chasing Life
8,215 Listeners